Samantha Hollingworth

Pharmacy Practice

About

Staff has not updated content!

Research Summary

(inferred from publications by AI)

Global health challenges and medication use patterns across diverse settings highlight significant trends in public health interventions. Studies reveal how medication adherence varies by demographics and geographic regions, impacting outcomes like mental health and cardiovascular disease. Advanced pharmacological studies demonstrate the efficacy of drugs in managing chronic conditions such as heart disease and diabetes, while recent epidemiological research underscores the importance of understanding drug use patterns to improve healthcare policies. Furthermore, research on adverse drug reactions highlights the need for robust monitoring systems to prevent harm.

Research Themes

All Papers

International trends in clozapine use: a study in 17 countries(2017)

The impact of clozapine on hospital use: a systematic review and meta‐analysis(2017)

Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis(2020)

Patterns of Antipsychotic Medication Use in Australia 2002–2007(2010)

Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013(2015)

Clozapine-induced myocarditis: Separating the wheat from the chaff(2014)

Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study(2021)

Clozapine in the community: Improved access or risky free-for-all?(2015)

Clozapine use and prevalence in Australia 2016–2020(2021)

Affective and anxiety disorders: prevalence, treatment and antidepressant medication use.(2010)

Marked increase in proton pump inhibitors use in Australia(2010)

Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison(2019)

Treatment of clozapine‐associated obesity and diabetes with exenatide in adults with schizophrenia: <scp>A</scp> randomized controlled trial ( <scp>CODEX</scp> )(2017)

Measuring Medicine Use: Applying ATC/DDD Methodology to Real-World Data(2021)

Prescribing trends in cognition enhancing drugs in Australia(2010)

Pharmacy workforce to prevent and manage non-communicable diseases in developing nations: The case of Nepal(2015)

How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review(2022)

Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders’ capacity, needs, policy areas of demand and perspectives in Nigeria(2020)

Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process(2019)

Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis(2021)

What do we need to know? Data sources to support evidence-based decisions using health technology assessment in Ghana(2020)

Health technology assessment capacity at national level in sub-Saharan Africa: an initial survey of stakeholders(2020)

Psychiatric Drug Prescribing in Elderly Australians: Time for Action(2011)

Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review(2022)

Economic evaluations of non-communicable diseases conducted in Sub-Saharan Africa: a critical review of data sources(2023)

Health Technology Assessment and priority setting for Universal Health Coverage: A qualitative study of stakeholders capacity, needs, policy areas of demand and perspectives in Nigeria(2020)

Anxiolytic, hypnotic and sedative medication use in Australia(2010)

Changing patterns of antiepileptic drug use in pregnant Australian women(2009)

Antiepileptic drugs in Australia: 2002–2007(2009)

The prescribing of antiepileptic drugs for pregnant Australian women(2011)

Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose(2018)

Opioid analgesic prescribing in Australia: a focus on gender and age(2015)

Why aren’t Australian pharmacists supplying naloxone? Findings from a qualitative study(2019)

Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia(2013)

Opioid analgesic use in Australia and The Netherlands: a cross-country comparison(2017)

Dental opioid prescribing rates after the up-scheduling of codeine in Australia(2020)

How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities(2019)

Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years(2020)

Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit(2018)

Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, Australia(2020)

Multiple opioid prescribers: A genuine quest for treatment rather than aberrant behaviour. A two-decade population-based study(2020)

Opioid medication prescribing in Queensland, 1997‒2018: a population study(2021)

Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia(2019)

Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes(2016)

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial(2015)

Prescribing patterns of dental practitioners in Australia from 2001 to 2012. Antimicrobials(2016)

Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy(2015)

Trends in Australian dental prescribing of antibiotics: 2005–2016(2021)

Antibiotic use in Australian and Swedish primary care: a cross-country comparison(2022)

Antimicrobial stewardship: Prescribing across the primary care health professions(2023)

‘Repeat’ prescriptions and antibiotic resistance: findings from Australian community pharmacy(2016)

The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies(2017)

Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre(2021)

Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia(2019)

Sociodemographic correlates of antidepressant utilisation in Australia(2009)

Australian National Trends in Stimulant Dispensing: 2002–2009(2010)

Prescribing patterns of analgesics and other medicines by dental practitioners in Australia from 2001 to 2012(2017)

Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life(2018)

Using Prescription and Wastewater Data to Estimate the Correction Factors of Atenolol, Carbamazepine, and Naproxen for Wastewater-Based Epidemiology Applications(2021)

Community-based integrated care versus hospital outpatient care for managing patients with complex type 2 diabetes: costing analysis*(2020)

Impact of a general practitioner-led integrated model of care on the cost of potentially preventable diabetes-related hospitalisations(2017)

Antidepressant use in Australia and Sweden—A cross‐country comparison(2020)

Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study(2016)

Use of Healthcare Services by Patients with Non-Communicable Diseases in Nepal: A Qualitative Study with Healthcare Providers(2017)

Utilization of anti‐Parkinson drugs in Australia: 1995–2009(2011)

Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal(2019)

Case conference primary-secondary care planning at end of life can reduce the cost of hospitalisations(2016)

A new model of integrated primary-secondary care for complex diabetes in the community: study protocol for a randomised controlled trial(2013)

Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?(2019)

Trends in Systemic Antifungal Use in Australia, 2005–2016: a Time-Series Analysis(2021)

Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors(2022)

A Review of Medication Use as an Indicator of Human Health Impact in Environmentally Stressed Areas(2016)

Nurse practitioner and midwife antibiotic prescribing in Australia(2023)

The trigger for parturition in sheep: fetal hypothalamus or placenta?(1991)

Continuous intrafetal infusion of prostaglandin E2 prematurely activates the hypothalamo-pituitary-adrenal axis and induces parturition in sheep.(1996)

Chronic administration of low doses of adrenocorticotropin to hypophysectomized fetal sheep leads to normal term labor.(1994)

In Australia are people born in other countries at higher risk of road trauma than locally born people?(2003)

Ezetimibe: Use, costs, and adverse events in Australia(2016)

Associations of Guideline Recommended Medications for Acute Coronary Syndromes With Fall-Related Hospitalizations and Cardiovascular Events in Older Women With Ischemic Heart Disease(2016)

Effects of decentralisation and health system reform on health workforce and quality‐of‐care in Indonesia, 1993–2007(2014)

Medicine use during acute and chronic postinjury periods in whiplash-injured individuals(2018)

Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis(2013)

Disease modifying therapies for relapsing-remitting multiple sclerosis: Use and costs in Australia (1996-2019)(2021)

Multiple sclerosis disease modifying medicine utilisation in Australia(2014)

Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia.(2018)

Forecasting the amount and cost of medicine to treat type 2 diabetes mellitus in Nepal using knowledge on medicine usage from a developed country(2018)

Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center(2020)

Dopamine Agonists: Time Pattern of Adverse Effects Reporting in Australia(2015)

Research governance authorisation: the next frontier(2021)

Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies(2021)

Triptan use in Australia 1997-2015: A pharmacoepidemiological study(2017)

The impact of COVID-19 on antidepressant sales and prescription dispensing in Australia(2021)

Effect of Late Hypothalamo‐Pituitary Disconnection on the Development of the HPA Axis in the Ovine Fetus and the Initiation of Parturition(1994)

Prostaglandin G/H synthase activity in ovine cotyledons: a gestational profile.(1990)

Secondary Prevention of Osteoporosis in Australia(2010)

National trends in the community prescribing of second-generation antipsychotic medications in Australian children and youth: the incomplete story(2013)

Bortezomib use and outcomes for the treatment of multiple myeloma(2020)

Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting(2017)

Does consumer medicines interest reflect medicines use? An observational study comparing medicines call center queries with medicines use(2018)

Collaboration Network

No collaborations found in the dataset.

About This Profile

This profile is generated from publicly available publication metadata and is intended for research discovery purposes. Themes, summaries, and trajectories are inferred computationally and may not capture the full scope of the lecturer's work. For authoritative information, please refer to the official KNUST profile.